Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is WillScot WSC stock approaching trendline support Buying Pressure 20260420 Materialise MTLS Stock Slides 046 20260420 Market Wrap Tech leads sector gains as consumer stocks lag amid mild market dips Is WEX Inc WEX stock entering a consolidation phase Slight Gain 20260420 Is Marker Therapeutics MRKR stock moving unpredictably Ticks Down 20260424 How Interactive Strength TRNR manages tail risk exposure Interactive Strength posts big loss huge EPS miss Applied Materials Inc AMAT Outperforming Semiconductor Leader Amid Broader Tech Sector Earnings Strength L3Harris Technologies LHX Dividend Commitment and Propulsion Segment Expansion Signal Aligned LongTerm National Security Exposure Is now a good time to buy Sharplink SBET stock today Q4 2025 Earnings Fall Short Fate Therapeutics FATE Stock Slides 313 Support at 161 20260518 DXL DXLG Falls 352 Watching 066 Support 20260518 KVH Industries KVHI Stock Analysis Climbs 146 Eyes on 1169 20260514 Reid Hoffman Secures 246 Million to Launch AIPowered Cancer Research Startup Manas AI Fortress Biotech FBIO Q4 2025 Earnings Miss Sparks Concern What Cal Resource CRCs 192 Jump Means for Investors 20260521 Photronics PLAB Delivers Q1 2026 Beat EPS 061 vs 055 Expected TCW TSI Unchanged at 451 RangeBound Trading 20260520 FLY Q1 2026 Earnings EPS Beats Estimates as PreRevenue Aerospace Company Advances COKE Q1 2026 Earnings EPS of 179 Reported Stock Edges Lower Payoneer Global Inc PAYO Q1 2026 Earnings EPS Beat Delivers 32 Surprise Amid Revenue Disclosures CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue CF Q1 2026 Earnings Strong Earnings Beat Amid Stable Fertilizer Market Salesforce CRM Edges Higher as Investors Eye Cloud Growth and Key Resistance Intergroup Corporation INTG Rallies 35 as Stock Approaches Resistance Quanta Services PWR Faces Minor Pullback Maintains Position Above Crucial Support Design Therapeutics DSGN Consolidates Near Support After Marginal Decline